Olympia Diagnostics, Inc.

Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to identify and validate biomarkers important for cancer tumorigenesis, progression and metastasis. We developed biomarker-panels that are able to detect and diagnosis cancer, distinguish aggressive and non-aggressive cancer, distinguish metastatic and non-metastatic cancer, and predict cancer recurrence and patient survival, with very high sensitivity and specificity. We have developed four novel products for prostate cancer diagnosis and prognosis that can accurately diagnose prostate cancer and give treatment guidance.